Family Beginnings IVF

What Family Beginnings IVF does

Family Beginnings IVF (legal name Family Beginnings P.C.) is a single-location fertility clinic and IVF laboratory based in Indianapolis, Indiana, founded and led by Dr. James G. Donahue, an REI-fellowship-trained physician who also holds the rare High Complexity Laboratory Director (HCLD) credential. The practice, which operated independently from the mid-1990s and opened its current purpose-built facility in 2008, provides a comprehensive ART service line covering fertility evaluation, IUI, conventional IVF, ICSI, INVOcell intra-vaginal culture, frozen embryo transfer, preimplantation genetic testing (PGT-A and PGT-M via NGS), vitrification-based cryopreservation, assisted hatching, donor services, LGBT family-building (including reciprocal IVF), oncology fertility preservation, and in-house psychological counseling. Underlying technology includes a CAP-accredited, ground-up-built embryology lab with HEPA/charcoal-filtered positive-pressure air and adjacent retrieval and culture rooms, NGS-based genetic testing sent to third-party labs, and publication of age-stratified euploid embryo rate benchmarks.

The clinic generates revenue on a fee-for-service, pay-as-you-go basis through episode-based treatment cycles and one-time diagnostic procedures, with pricing determined by direct quote rather than published rate cards; INVOcell is positioned at roughly half the cost of a standard IVF cycle to capture price-sensitive patients, and third-party financing partnerships (United Medical Credit, CapexMD, LendingClub, Freedom Fertility, EMD Serono Compassionate Care) address affordability gaps. Go-to-market is direct-to-consumer: patients initiate contact by phone or email, and acquisition is driven primarily by OB/GYN physician referrals, website content, and patient testimonials. Family Beginnings is the first and only AAAASF-accredited IVF facility in Indiana and holds stacked accreditations (CAP, CLIA, ASRM/SART, FDA HCT/P, ABB) that serve as credibility and regulatory entry barriers.

Following the December 17, 2025 definitive agreement, INVO Fertility, Inc. (NASDAQ:IVF) completed the acquisition of Family Beginnings, P.C. on February 19, 2026 for $750,000, making it INVO Fertility's fourth operational U.S. fertility clinic. Family Beginnings generated approximately $1.2 million in revenue and roughly $0.2 million in net income for the twelve months ending September 30, 2025.

Name

Family Beginnings IVF

Legal name

Family Beginnings P.C.

Website

https://ivf-indiana.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

1–10 employees

Short description

Family Beginnings IVF is a single-location Indianapolis fertility clinic and IVF laboratory serving Central Indiana and the broader Midwest with comprehensive ART services, led by an MD/HCLD-certified founder since 1995 and acquired by INVO Fertility in February 2026.

Ownership category

akta.pro rank

Product category

Fertility Clinic Services

NAICS

Family Planning Centers (621410)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industries

Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)

Keywords

• In-vitro fertilization services
• Fertility clinic treatments
• Assisted reproductive technology
• Preimplantation genetic testing
• INVOcell intra-vaginal culture

Headquarters

HQ city

Indianapolis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Fertility Treatment Services: Family Beginnings generates revenue by providing fee-for-service fertility treatments and procedures directly to patients. Revenue is one-time/episode-based per treatment cycle (IVF, ICSI, INVOcell, IUI, FET, cryopreservation, donor services, genetic testing, counseling). The clinic also generates approximately $1.2 million in annual revenue per available financial data from the acquisition context (12 months ending September 30, 2025). Pricing is not publicly listed; patients are directed to call for costs.
2. Diagnostic and Laboratory Services: Revenue from diagnostic procedures (hysterosalpingogram, hysteroscopy, laparoscopy, saline infusion sonogram, endometrial receptivity assay) and on-site laboratory services (hormone testing, semen analysis, AMH testing). Billed per procedure or lab service.
3. Donor Services: Donor sperm, donor oocytes, and donor embryo services. Revenue generated per cycle or procedure involving third-party reproductive materials. Counseling is mandatory for third-party reproduction per ASRM guidelines and included in the service offering.
4. Cryopreservation and Storage: Embryo, sperm, and egg cryopreservation services using vitrification. On-site storage in liquid nitrogen at -196°C. Revenue per cryopreservation cycle and storage fees.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Family Beginnings is a single-location fertility clinic in Indianapolis that sells comprehensive assisted reproductive technology (ART) services directly to patients, including in-vitro fertilization (IVF), the INVOcell intra-vaginal culture system, ICSI, frozen embryo transfer, preimplantation genetic testing (PGT), vitrification-based cryopreservation, donor services, diagnostic procedures, fertility evaluation, and psychological counseling. Pricing is quote-based, with INVOcell explicitly positioned at approximately half the cost of a conventional IVF cycle.

Product overview

Family Beginnings is a single-location fertility clinic offering a comprehensive range of assisted reproductive technology (ART) services. The core portfolio centers on INVOcell (an intra-vaginal culture system as an affordable IVF alternative), conventional IVF, ICSI, FET, PGT genetic testing, cryopreservation, and assisted hatching. The clinic provides supporting services including donor services (sperm, eggs, embryos), fertility evaluation, diagnostic procedures, counseling, and LGBT-focused treatments. The practice emphasizes affordable fertility care with over 20 years of experience serving Central Indiana, having pioneered several reproductive technology firsts in the state including the first INVOcell pregnancy documented in 2017.

Differentiator

Problem solved

Functional benefit

Products and services

• INVOcell An intra-vaginal culture (IVC) system where embryos develop inside a device placed in the upper cavity of the vagina using the body's natural temperature and gas exchange, enabling in vivo fertilization instead of laboratory incubation. Offered to fertility patients seeking IVF-equivalent pregnancy outcomes at approximately half the cost of a standard IVF cycle, with ICSI performed on all INVOcell cycles.
• IVF (In Vitro Fertilization) A process in which eggs and sperm are combined in a laboratory, embryos are cultured in incubators, and resulting embryos are transferred into the uterus, including ovarian stimulation, egg retrieval, embryo growth, and embryo transfer. Intended for individuals and couples who need advanced reproductive assistance beyond IUI or ovulation induction.
• OI/IUI (Ovulation Induction / Intrauterine Insemination) Ovulation induction medication is used to stimulate ovarian egg production, and intrauterine insemination places processed sperm directly into the uterus around ovulation time to increase pregnancy chances. Targets patients with mild infertility factors and those seeking a lower-cost treatment before IVF.
• ICSI (Intracytoplasmic Sperm Injection) A laboratory procedure in which micromanipulation is used to insert a single sperm cell directly into an egg. Indicated for male factor infertility or for patients with prior failed fertilization during conventional IVF, including all INVOcell cycles at the practice.
• FET (Frozen Embryo Transfer) Transfer of embryos that have been previously frozen via vitrification into the uterus, often paired with ERA testing to personalize implantation timing. Serves patients with stored embryos from a prior IVF cycle, donor embryo recipients, and those pursuing preimplantation genetic testing workflows.
• PGT (Preimplantation Genetic Testing) Embryo biopsy screening comprising PGT-A (aneuploidy screening) and PGT-M (monogenic / single-gene defect testing) using Next Generation Sequencing (NGS) technology at an outside genetics laboratory. Used to identify euploid embryos prior to transfer or cryopreservation and to avoid passing on known heritable disorders.
• Cryopreservation Vitrification freezing and storage of embryos, sperm, and eggs in liquid nitrogen at -196°C, with storage on-site at the clinic's laboratory. Offered to fertility preservation patients and as a component of IVF and donor service treatment plans.
• Assisted Hatching A laser-based procedure that creates a small hole in the embryo's zona pellucida to improve implantation rates, performed at embryo transfer, prior to cryopreservation, or before PGT biopsy. Indicated for selected patients where implantation success is otherwise at risk.
• Donor Services Third-party reproduction services including donor sperm, anonymous and directed egg donation, and embryo adoption/donation, accompanied by FDA-compliant donor screening and mandatory pre-treatment counseling. Targets single patients, LGBT couples, and heterosexual couples needing donor gametes or embryos to build their families.
• Fertility Evaluation Comprehensive male and female fertility assessment including medical history, physical examination, diagnostic testing, and semen analysis. The standard entry point for new patients, used to determine the cause of infertility and direct patients to the appropriate treatment pathway.
• Diagnostic Services Diagnostic procedures including the Endometrial Receptivity Assay (ERA, profiling over 270 molecules associated with implantation), Hysterosalpingogram (HSG), Hysteroscopy, Laparoscopy, and Saline Infusion Sonogram (SIS). Used to evaluate uterine and tubal anatomy and to personalize the implantation window prior to embryo transfer.
• Counseling Services In-house psychological counseling for patients addressing the emotional aspects of infertility, treatment decisions, and family-building stress, delivered by Renate Donahue, LCSW. Mandatory for third-party reproduction patients per ASRM guidelines and offered to all patients as part of the practice's integrated care model.
• LGBT Services Dedicated assisted reproductive services for the LGBT community including reciprocal IVF, gestational surrogacy, donor sperm/egg services, and egg/sperm freezing. Integrated into the practice's broader ART offerings and supported by mandatory third-party reproduction counseling.

Quantifiable outcome

• Approximately 80% of ICSI-injected eggs form embryos in INVOcell cycles, comparable to conventional IVF rates
• +4 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core and minor.

• INVO Fertility / INVO Centers LLC (Parent Company)coreStrategic or Co-development Partner · 19 February 2026INVO Fertility, Inc. (NASDAQ:IVF) acquired Family Beginnings, P.C. through its wholly owned subsidiary INVO Centers LLC for $750,000. The definitive purchase agreement was signed December 17, 2025, and the transaction closed February 19, 2026. Family Beginnings became INVO Fertility's fourth operational fertility clinic in the United States. The acquisition is intended to expand INVO Fertility's footprint in the fertility healthcare sector and the Midwest. Family Beginnings generated approximately $1.2 million in revenue for the 12 months ending September 30, 2025.
• INVO BiosciencescoreTechnology or Integration · 1 January 2017Family Beginnings was the first clinic in Indiana to offer INVOcell, a proprietary intra-vaginal culture system developed by INVO Biosciences. The clinic began offering INVOcell in 2017 and welcomed the first INVOcell babies in Indiana. The INVOcell device enables fertilization to occur inside the woman's body rather than in a laboratory, reducing costs while maintaining near-IVF pregnancy rates.
• EMD Serono (Compassionate Care Program)minorOthersFamily Beginnings refers patients to EMD Serono's Compassionate Care Program for significant savings on fertility medications. The program is prominently featured on the clinic's website and financial resources page.
• United Medical CreditminorOthersFamily Beginnings refers patients to United Medical Credit for financing options for fertility treatment costs. United Medical Credit offers specialized fertility financing products for patients who need payment plan options.
• Freedom Fertility Pharmacy (with CapexMD and LendingClub)minorOthersFamily Beginnings refers patients to Freedom Fertility Pharmacy, which partners with CapexMD and LendingClub to offer loans and financing solutions specifically for fertility patients' medication costs.

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

Emerging players

• Kindbody: Tech-forward, venture-backed fertility chain emphasizing employer contracts and modern patient experience with full IVF/egg-freezing services. Comparable end-to-end ART services but differentiated by digital-first GTM vs. Family Beginnings' traditional clinic model.
• Extend Fertility: Specialty fertility clinic focused primarily on elective egg freezing and IVF in urban markets. Comparable clinical laboratory and embryology operations but narrower service focus than Family Beginnings' full ART portfolio.

Direct peers

• Boston IVF: Large multi-clinic fertility network operating across the U.S. with full ART services (IVF, ICSI, PGT, donor, egg freezing), competing for the same self-pay patient base. Comparable scale of physician-staffed clinical and embryology operations.
• Shady Grove Fertility: One of the largest U.S. fertility clinic networks (part of US Fertility) offering IVF, ICSI, donor, PGT, and shared-risk/refund programs. Directly comparable across service breadth, employer contracts, and physician referral flow.
• Prelude Fertility: Parent organization of multiple fertility clinics (including reproductive endocrinologist-led practices), offering a consolidated platform for clinic roll-ups. Comparable as a competing consolidator and direct operating-model peer.
• Fertility Centers of Illinois: Large multi-location Midwest-based fertility practice offering IVF, PGT, donor services, and egg freezing. Comparable on geographic catchment and full-service ART menu serving a comparable regional self-pay patient base.
• Reproductive Medicine Associates (RMA Network): Multi-site fertility clinic network with full ART services, strong SART-reported outcomes, and regional branch model serving both insured and self-pay patients. Directly comparable across clinic operations and physician staffing.
• INVO Fertility: Public parent of Family Beginnings (NASDAQ:IVF) and operator of a multi-clinic fertility network using both conventional IVF and proprietary INVOcell. Most directly comparable given shared ownership, overlapping INVOcell technology, and clinic-level operating model.
• CCRM Fertility: National fertility clinic network (under Unified Women's Healthcare) with full ART service line, advanced lab capabilities, and physician-owned branch model. Comparable on multi-site ART delivery and published SART outcomes.

Broad incumbents

• US Fertility: Large fertility clinic platform (backed by Amulet Capital Partners) operating multiple regional brands including Shady Grove Fertility. Comparable as a broader consolidator in the U.S. fertility clinic market and as a competing operating-platform model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks4 records

Key highlights8 records

Customer concentration

• YouTubeyoutube.com/channel/UC3UKCVeS_joxLpUeIHnG9VQ
• Facebookfacebook.com/Family-Beginnings-213625992366396

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Family Beginnings IVF